Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Lu-177-DOTATATE

Aliases
Lu-177
Name
Lu-177

2 clinical trials

1 drug

4 indications

Indication
Pheochromocytoma
Indication
Paraganglioma
Indication
Neuroendocrine Tumors
Indication
Gastroenteropancreatic Tumors
Drug
Lutetium (177Lu) oxodotreotide
Clinical trial
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Status: Recruiting, Estimated PCD: 2025-07-01